Vector Science & Therapeutics announces cGMP manufacturing agreement with LyoGenesis Plus for its proprietary peptide portfolio
Vector Science & Therapeutics Chas entered an exclusive licensing and manufacturing agreement with LyoGenesis Plus, a cGMP lyophilisation and...
Reacta Healthcare receives extended MHRA pharmaceutical manufacturer’s licence and GMP certificate
Reacta Healthcare, a leading developer and manufacturer of pharmaceutical-grade oral food challenge (OFC) products for food allergy diagnostics, has...
Deora from Stevanato, a new proprietary pen injector platform targeting incretin-based therapies
Stevanato Group, a leading global provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and...
Reacta Healthcare receives extended MHRA pharmaceutical manufacturer’s licence and GMP certificate
Reacta Healthcare, a leading developer and manufacturer of pharmaceutical-grade oral food challenge (OFC) products for food allergy diagnostics, has...
Reprocell submits application for manufacturing and marketing approval in Japan for stem cell therapy Stemchymal for spinocerebellar ataxia
Reprocell has submitted an application for manufacturing and marketing approval in Japan for the regenerative medicine product Stemchymal®, for...
Alcami to acquire contract packaging organisation Tjoapack
Alcami Corporation, a leading US-based contract development and manufacturing organisation (CDMO), has entered into a definitive agreement to acquire...
Alcami to acquire contract packaging organisation Tjoapack
Alcami Corporation, a leading US-based contract development and manufacturing organisation (CDMO), has entered into a definitive agreement to acquire...
PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish and drug-device delivery combination capabilities
PCI Pharma Services, a world-leading integrated global contract development and manufacturing organisation (CDMO) focused on innovative biologic and small...
4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility...
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, has announced a significant expansion...
Delivery routes expanded and order cut-off times for midwest and west coast customers extended
Smith Drug Company, the industry's largest wholesaler dedicated exclusively to independent retail and long-term care pharmacies, has announced a...
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it...
Samsung Biologics expands US manufacturing capacity with acquisition from GSK
Samsung Biologics has announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
Popular
© 2026 Pharma Press Publishing.